Evidence map›Paper›PMID 36558562›Full record

ArticleNutrients2022

Role of Zerumbone, a Phytochemical Sesquiterpenoid from

Wei-Lan Yeh, Bor-Ren Huang, Guan-Wei Chen, Vichuda Charoensaensuk, Cheng-Fang Tsai, Liang-Yo Yang, Dah-Yuu Lu, Mao-Kai Chen, Chingju Lin

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Zerumbone reduces TLR2 stimulation-induced M1 macrophage polarization pattern via upregulation of Nrf-2 expression in murine macrophages.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Wei-Lan YehDepartment of Biochemistry, School of Medicine, China Medical University, Taichung 40402, Taiwan.ORCID 0000-0003-4398-7610
Bor-Ren HuangDepartment of Neurosurgery, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung 427213, Taiwan.
Guan-Wei ChenInstitute of Translational Medicine and New Drug Development, China Medical University, Taichung 40402, Taiwan.
Vichuda CharoensaensukDepartment of Pharmacology, School of Medicine, College of Medicine, China Medical University, Taichung 40402, Taiwan.
Cheng-Fang TsaiDepartment of Medical Laboratory Science and Biotechnology, Asia University, Taichung 41354, Taiwan.
Liang-Yo YangDepartment of Physiology, School of Medicine, China Medical University, Taichung 40402, Taiwan.
Dah-Yuu LuDepartment of Pharmacology, School of Medicine, College of Medicine, China Medical University, Taichung 40402, Taiwan.ORCID 0000-0002-4463-5919
Mao-Kai ChenDepartment of Anesthesiology, China Medical University Hospital, Taichung 404327, Taiwan.
Chingju LinDepartment of Physiology, School of Medicine, China Medical University, Taichung 40402, Taiwan.
China Medical University · TWAsia University · TWTzu Chi University · TW

Funding

Ministry of Science and Technology (MOST109-2320-B-039 -020 and MOST 111-2320-B-039-028-
6 · The paper itself

Abstract

Macrophages and microglia are highly versatile cells that can be polarized into M1 and M2 phenotypes in response to diverse environmental stimuli, thus exhibiting different biological functions. In the central nervous system, activated resident macrophages and microglial cells trigger the production of proinflammatory mediators that contribute to neurodegenerative diseases and psychiatric disorders. Therefore, modulating the activation of macrophages and microglia by optimizing the inflammatory environment is beneficial for disease management. Several naturally occurring compounds have been reported to have anti-inflammatory and neuroprotective properties. Zerumbone is a phytochemical sesquiterpenoid and also a cyclic ketone isolated from Zingiber zerumbet Smith. In this study, we found that zerumbone effectively reduced the expression of lipocalin-2 in macrophages and microglial cell lines. Lipocalin-2, also known as neutrophil gelatinase-associated lipocalin (NGAL), has been characterized as an adipokine/cytokine implicated in inflammation. Moreover, supplement with zerumbone inhibited reactive oxygen species production. Phagocytic activity was decreased following the zerumbone supplement. In addition, the zerumbone supplement remarkably reduced the production of M1-polarization-associated chemokines CXC10 and CCL-2, as well as M1-polarization-associated cytokines interleukin (IL)-6, IL-1β, and tumor necrosis factor-α. Furthermore, the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 and the production of NO were attenuated in macrophages and microglial cells supplemented with zerumbone. Notably, we discovered that zerumbone effectively promoted the production of the endogenous antioxidants heme oxygenase-1, glutamate-cysteine ligase modifier subunit, glutamate-cysteine ligase catalytic subunit, and NAD(P)H quinone oxidoreductase-1 and remarkably enhanced IL-10, a marker of M2 macrophage polarization. Endogenous antioxidant production and M2 macrophage polarization were increased through activation of the AMPK/Akt and Akt/GSK3 signaling pathways. In summary, this study demonstrated the protective role of zerumbone in maintaining M1 and M2 polarization homeostasis by decreasing inflammatory responses and enhancing the production of endogenous antioxidants in both macrophages and microglia cells. This study suggests that zerumbone can be used as a potential therapeutic drug for the supplement of neuroinflammatory diseases.

Indexed as

Glutamate-Cysteine LigaseSesquiterpenesAntioxidantsCytokinesGlycogen Synthase Kinase 3Interleukin-6Lipocalin-2MacrophagesMicrogliaOxidation-ReductionProto-Oncogene Proteins c-aktAntioxidantsCytokinesGlutamate-Cysteine LigaseGlycogen Synthase Kinase 3Interleukin-6Lipocalin-2Proto-Oncogene Proteins c-aktSesquiterpeneszerumbonemacrophage polarizationmicroglial cellsneuroinflammationredox homeostasiszerumbone

Identifiers

PMID36558562
PMCPMC9783216
OpenAlexW4312196574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.